This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Non-dihydropyridine calcium channel antagonists in rate control in atrial fibrillation (AF)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Non-dihydropyridine calcium channel antagonists in control of rate in atrial fibrillation (1)

Usual oral maintenance dose

verapamil

40 mg b.i.d. to 360 mg (ER) o.d.

diltiazem

60 mg t.i.d. to 360 mg (ER) o.d.

ER = extended release formulations

Reference:

  • (1) Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Guidelines for the management of atrial fibrillation. European Heart Journal (2010) 31, 2369-2429.

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page